Safety and cardiovascular effects of multiple‐dose administration of aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021 - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library

Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders - Juza - 2023 - Medicinal Research Reviews - Wiley Online Library

Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics

Full article: Safety and efficacy of aripiprazole 2-month ready-to-use 960 mg: secondary analysis of outcomes in adult patients with bipolar I disorder in a randomized, open-label, parallel-arm, pivotal study

Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis - The Lancet

Schizophrenia and Related Psychoses - Major Reference Works - Wiley Online Library

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease

Impact of CYP2C19 Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic‐Pharmacokinetic Prospective Multicenter Study - Blanco‐Dorado - 2020 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects

A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder

Schizophrenia and Related Psychoses - Major Reference Works - Wiley Online Library

PDF) Evidence-Based Recommendations for Monitoring Safety of Second Generation Antipsychotics in Children and Youth

Frontiers Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone

PDF) Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial

Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders - Juza - 2023 - Medicinal Research Reviews - Wiley Online Library